ArticleGenome medicine2009
Does genomic risk information motivate people to change their behavior?
Article in Genome medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Delivering genomic medicine in the United Kingdom National Health Service: a systematic review and narrative synthesis.Genetics in medicine : official journal of the American College of Medical Genetics · 2019Pooled it
- The Effects of Personalized Feedback About ALDH2*2, Alcohol Use, and Associated Health Risks on Drinking Intention and Consumption: The Role of Self-Efficacy and Perceived Threat.Alcohol, clinical & experimental research · 2026Trial
- A randomized trial of the clinical utility of genetic testing for obesity: design and implementation considerations.Clinical trials (London, England) · 2014Trial
- Evaluation of a brief web-based genetic feedback intervention for reducing alcohol-related health risks associated with ALDH2.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2010Trial
- Article
- Communication challenges for nongeneticist physicians relaying clinical genomic results.Personalized medicine · 2016Article
- Genetic causal beliefs about obesity, self-efficacy for weight control, and obesity-related behaviours in a middle-aged female cohort.Psychology & health · 2016Article
- Toward clinical genomics in everyday medicine: perspectives and recommendations.Expert review of molecular diagnostics · 2016Article
- Patient compliance based on genetic medicine: a literature review.Journal of community genetics · 2014Article
- Motivations for genetic testing for lung cancer risk among young smokers.Tobacco control · 2013Article
- You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative.Personalized medicine · 2011Article
- Young smokers' views of genetic susceptibility testing for lung cancer risk: minding unintended consequences.Journal of community genetics · 2011Article
- Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.Public health genomics · 2011Article
- Personal genomics and individual identities: motivations and moral imperatives of early users.New genetics and society · 2010Article
- Causal beliefs about obesity and associated health behaviors: results from a population-based survey.The international journal of behavioral nutrition and physical activity · 2010Article
- The past, present, and future of direct-to-consumer genetic tests.Dialogues in clinical neuroscience · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent flood of information about new gene variants associated with chronic disease risk from genome-wide association studies has understandably led to enthusiasm that genetic discoveries could reduce disease burdens and increase the availability of direct-to-consumer tests offering risk information. However, we suggest caution: if it is to be any benefit to health, genetic risk information needs to prompt individuals to pursue risk-reduction behaviors, yet early evidence suggests that genetic risk may not be an effective motivator of behavior change. It is not clear how genetic information will inform risk-based behavioral intervention, or what harms might occur. Research is needed that examines the behavioral consequences of genetic risk knowledge in the context of other motivators and social conditions, as well as research that determines the subgroups of people most likely to be motivated, in order to inform policy decisions about emerging genetic susceptibility tests. Without such research, it will not be possible to determine the appropriate health care uses for such tests, the impact on health care resources from consumer-initiated testing, or the criteria for truthful advertising of direct-to-consumer tests.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.